BioCentury
ARTICLE | Finance

Double-dipping

How rumored Relypsa takeout could add to 5AM's returns

April 18, 2016 7:00 AM UTC

If takeout rumors about Relypsa Inc. (NASDAQ:RLYP) come true, 5AM Ventures is well positioned to improve upon the returns it has already achieved on the second of two lucrative sibling investments in chronic kidney disease (CKD).

On April 7, Relypsa gained $9.81 (68%) to $24.32 after media reports said the company is considering a sale. 5AM Ventures is already in the money following a series of open market sales of the stock after Relypsa's 2013 IPO. ...